ALTO-101

N/A

Report date: 2025/10/15 17:03:28
NME

Base Information

Drug NameALTO-101
Drug Alias NameALTO-101ALTO101
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPhosphodieterase 4 inhibitors
TargetsPhosphodieterase 4
Therapy Area/IndicationsSchizophreniaCognition DisordersNeurodegenerative Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesAlto Neuroscience Inc
China Registration ClassN/A

Develop Information

Active CompaniesAlto Neuroscience Inc
Inactive CompaniesN/A
Active IndicationsSchizophreniaCognition Disorders
Inactive IndicationsNeurodegenerative Diseases

Other Information

ATC CodeN/A
Related LinksN/A